NOS1AP Is a Genetic Modifier of the Long-QT Syndrome

Identification of a Schizophrenia-Associated Functional Noncoding Variant inNOS1AP

(2009) Naomi S. Wratten et al.   AMERICAN JOURNAL OF PSYCHIATRY

Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease

(2009) Sumeet S. Chugh et al.   CIRCULATION

Genetic Variations in Nitric Oxide Synthase 1 Adaptor Protein Are Associated With Sudden Cardiac Death in US White Community-Based Populations

(2009) W.H. Linda Kao et al.   CIRCULATION

Common variants at ten loci modulate the QT interval duration in the QTSCD Study

(2009) Arne Pfeufer et al.   NATURE GENETICS

Common variants at ten loci influence QT interval duration in the QTGEN Study

(2009) Christopher Newton-Cheh et al.   NATURE GENETICS

Multiple Independent Genetic Factors at NOS1AP Modulate the QT Interval in a Multi-Ethnic Population

(2009) Dan E. Arking et al.   PLoS One

A commonNOS1APgenetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers

(2008) Matthijs L. Becker et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Association of NOS1AP Genetic Variants With QT Interval Duration in Families From the Diabetes Heart Study

(2008) A. B. Lehtinen et al.   DIABETES

Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration

(2008) M. Eijgelsheim et al.   HUMAN MOLECULAR GENETICS

Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations

(2008) Martin D Tobin et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart

(2008) K.-C. Chang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA